Experimental evidence indicates that arginine vasopressin (AVP) contributes to the release of ACTH under certain conditions. The present study investigates the role of vasopressin as a secretagogue of ACTH during cigarette smoking or nicotine infusion with additional injection of corticotropin releasing hormone (CRH) and using the specific AVP antagonist d(CH2)5Tyr(Me)-AVP. We first tested the effect of the AVP antagonist (10 μg/kg body weight i.v.) on ACTH and cortisol release following cigarette smoking in 15 healthy young male smokers. Smoking led to marked increments in plasma nicotine and to a small rise in plasma ACTH and cortisol. Mean plasma ACTH and cortisol levels were at no time significantly altered by the antagonist. This might be due to a slight agonistic effect of the AVP antagonist, to high interindividual variability of the ACTH and cortisol responses after smoking or to a neglegible role of AVP in smoking-induced ACTH release. In a second study we performed the following tests in six healthy male non-smokers: (1) nicotine infusion (1.0 μg/kg body weight per min); (2) CRH i.v. (100 μg); (3) AVP antagonist i.v. (5 μg/ kg); (4) nicotine infusion plus CRH i.v.; (5) nicotine infusion plus AVP antagonist i.v. ; (6) nicotine infusion plus CRH and AVP antagonist i.v.; and (7) sham infusion. Nicotine infusion led to greater increments of AVP, ACTH and cortisol than smoking without causing nausea. Peak nicotine levels after nicotine infusion were lower than after smoking. The AVP antagonist in the reduced dosage given alone had no effect on hormone levels. However, it slightly attenuated the effect of nico tite on ACTH and cortisol (P<0.05, ANOVA). Nicotine and CRH given together stimulated AACH and cortisol in a less than additive manner. The combined effect of nicotine and CRH was not inhibited by the antagonist. Our results indicate that the effect of nicotine on ACTH and cortisol may be partly mediated by hypothalamic AVP. Nicotine may also enhance CRH release by stimulating acetylcholine receptors of hypothalamic CRH neurons.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
analysis of variance
corticotropin releasing hormone
potassium; d (CH2)5 Tyr(Me)-
Beardwell CG (1971) Radioimmunoassay of arginine-vasopressin in human plasma. J Clin Endocrinol Metab 33:254–260.
Benowitz NL, Jacob P III, Jones RT, Rosenberg J (1982) Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221:368–372.
Bichet DG, Arthus M-F, Barjon JN, Lonergan M, Kortas C (1987) Human platelet fraction arginine-vasopressin. J Clin Invest 79:881–887.
Brenner T, Mizrachi R, Bodoff M, Weidenfeld J (1986) Evidence that central nicotine-acetylcholine receptors are involved in the modulation of basal and stress-induced adrenocortical response. Exp Neurol 94:735–743.
Calogero AE, Gallucci WT, Bernardini R, Saoutis C, Gold PW, Chrousos GP (1988) Effect of cholinergic agonists and antagonists on rat hypothalamaic corticotropin-releasing hormone secretin in vitro. Neuroendocrinology 47:303–308.
Chiodera P, Coiro V (1990) Inhition by dexamethasone of arginine vasopressin and ACTH responses to insulin-induced hypoglycaemia and cigarette smoking in normal men. Acta Endocrinol (Copenh) 123:487–492.
Chiodera P, Camellini L, Rossis G, Maffei ML, Volpi R, Coiro V (1984) Effect of clonidine on ACTH and cortisol release induced by cigarette smoking in man. Horm Metab Res 16:501–502.
DeBold CR, Sheldon WR, DeCherney GS, Jackson RV, Alexander AN, Vale W, Rivier J, Orth DN (1984) Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin releasing factor. J Clin Invest 73:533–538.
De Lorgeril M, Reinharz A, Busslinger B, Reber G, Righetti A (1985) Acute influence of cigarette smoke on platelets, catecholamine and neurophysins in the normal conditions of daily life. Eur Heart J 16:1063–1068.
Feyerabend C, Russell MAH (1979) Improved gaschromatographic method and microextraction technique for the measurement of nicotine in biological fluids. J Pharm Pharmacol 31:73–76.
Hader O, Bähr V, Hensen J, Hofbauer KG, Oelkers W (1990) Effects of a V1-vasopressin antagonist on ACTH release following vasopressin infusion or insulin-hypoglycemia in normal men. Acta Endocrinol (Copenh) 123:622–628.
Herning RI, Jones RT, Benowitz NL, Mines AH (1983) How a cigarette is smoked determines blood nicotine levels. Clin Pharmacol Ther 33:84–90.
Knepel W, Homolka L, Vlaskovska M, Nutto D (1984) In vitro adrenocorticotropin/β-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity. Endocrinology 114:1797–1804.
Kruszynski M, Lammek B, Manning M, Seto J, Haldar J, Sawyer WH (1980) [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid), 2-(O-methyl)tyrosine]argin-ine-vasopressin and [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)] arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem 23:364–368.
Matta SG, Singh J, Sharp BM (1990) Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors. Endocrinology 127:1646–1655.
Morton JJ, Connell JMC, Hughes MJ, Inglis GC, Wallace ECH (1985) The role of plasma osmolality, angiotensin II and dopamine in vasopressin release in man. Clin Endocrinol 23:129–138.
Porchet HC, Benowitz NL, Sheiner LB, Copeland JR (1987) Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J Clin Invest 80:1466–1471.
Porchet HC, Benowitz NL, Sheiner LB (1988) Pharmacodynamic model of tolerance: Application to nicotine. J Pharmacol Exp Ther 244:231–236.
Rivier C, Vale W (1983) Modulation of stress-induced ACTH-release by corticotropin releasing factor, catecholamines and vasopressin. Nature 305:325–327.
Rosenberg J, Benowitz NL, Jacob P, Wilson KM (1980) Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 28:517–522.
Scherer G, Jarczyk L., Heller W-D, Biber A, Neurath GB, Adlkofer F (1988) Pharmacokinetics of nicotine, cotinine and 3′-hydroxycotinine in cigarette smokers. Klin Wochenschr 66 [Suppl. XI]:5–11.
Sellini M, Sartori MP, Baccarini S, Bassi R (1987) Modificazioni dei livelli plasmatici di ACTH e di cortisoli in corso di assunzione di nicotina da fumo di sigaretta in soggetti normali fumatori e non fumatori. Boll Soc Ital Biol Sper 63:139–142.
Stalke J, Hader O, Hensen J, Bähr V, Scherer G, Oelkers W (1991) Nicotine infusion in man stimulates plasma-vasopressin, -ACTH and -cortisol in a dose dependent manner. In: Adlkofer F, Thurau K (eds) Effects of nicotine on biological systems. Birkhäuser, Basel Boston Berlin, pp 339–343.
Supported by a grant from Forschungsrat Rauchen und Gesundheit
About this article
Cite this article
Stalke, J., Hader, O., Bähr, V. et al. The role of vasopressin in the nicotine-induced stimulation of ACTH and cortisol in men. Clin Investig 70, 218–223 (1992). https://doi.org/10.1007/BF00184654